Archive for the ‘biomedcentral’ Category
Head-spinning: Publisher to post dozens of notices of concern following investigations into editors in chief
There are a number of threads to tie together here, so bear with us for a moment. First, BioMed Central, the publisher of Head & Neck Oncology, posted this statement on the journal’s homepage today: Read the rest of this entry »
A group of researchers in South Africa has lost their 2012 article in BMC Research Notes after one of the author’s institutions evidently pulled rank and sought to claim the data as its own.
The article, “Association of body weight and physical activity with blood pressure in a rural population in the Dikgale village of Limpopo Province in South Africa,” appeared last February. Its first author was Seth Mkhonto, who listed two affiliations, the Human Sciences Research Council, in Pretoria, and the University of the Limpopo.
But the latter institution seems not to have given Mkhonto approval to publish the data — a rather strange state of affairs given the whole “publish or perish” ethos of academia.
A group of psychiatric researchers in Norway has lost their 2013 paper in BMC Research Notes on the effects of antipsychotic medications on the brain after discovering that they’d botched their imaging analyses.
The article, “Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report,” came from a trio of scientists at the University of Bergen and Haukeland University Hospital, also in Bergen. According to the abstract of the paper, which was published last May:
Earlier this month we wrote about the retraction by Nature of a 19-year-old paper by Karel Bezouska, a former star researcher at Prague’s Charles University whose “dangerous and irresponsible deviations” from acceptable practice went as far as tampering with refrigerated samples to cover his tracks.
BMC Biotechnology has retracted another Bezouska paper, this one from 2011. He’s the second author on the article, titled “Heterologous expression, purification and characterization of nitrilase from Aspergillus niger K10.”
A technical hiccup led the Journal of Translational Medicine to double publish a 2012 paper by a pair of researchers from China and the United States, leading to a retraction.
The article is/was titled “Opportunities and challenges of disease biomarkers: a new section in the journal of translational medicine,” and it was written by Xiangdong Wang and Peter Ward — both members of the journal’s editorial board. It appeared in the Nov. 7, 2012 issue of the JTM. And it appeared less than a month later, on Dec. 5.
Just ask a group of Spanish researchers who published a 2011 paper in Proteome Science, then lost it this past April because they’d stolen text and a figure from previously published work — some, but not all of it, their own.